Schedule 13G ownership disclosure
SCICLONE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 80862K104
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 312,000
- Percent of class
- 0.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-15-000089
- Form type
- SC 13G
- Filer
- SCICLONE PHARMACEUTICALS INC
- CIK
- CIK 880771
- Filed
- Feb 06, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership